HomeProductsBioactive CompoundsProtein Kinase TargetsFGFRFutibatinib
Chemical structure of CAS 1448169-71-8

Futibatinib

CAS No.1448169-71-8
MDL No.N/A
MFC22H22N6O3
MW418.40
InChI KeyKEIPNCCJPRMIAX-HNNXBMFYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1448169-71-8
Product NameFutibatinib

Biological Targets

FGFR3·FGFR1·FGFR4·FGFR2

Associated Conditions

hepatocellular carcinoma·neoplasm·biliary tract neoplasm·cancer·soft tissue sarcoma·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Robust Response to Futibatinib in a Patient With Metastatic FGFR-Addicted Cholangiocarcinoma Previously Treated Using Pemigatinib.

Journal of the National Comprehensive Cancer Network : JNCCN • Vol. 20, Issue 5 • 2022
PMID: 35378504DOI: 10.6004/jnccn.2021.7121

Futibatinib Is a Novel Irreversible FGFR 1-4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors.

Cancer research • Vol. 80, Issue 22 • 2020
PMID: 32973082DOI: 10.1158/0008-5472.CAN-19-2568

TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma.

Cancer discovery • Vol. 9, Issue 8 • 2019
PMID: 31109923PMC: PMC6677584DOI: 10.1158/2159-8290.CD-19-0182

Reversible uncoupling of the copper and cobalt spin systems in cobalt bovine superoxide dismutase at low pH.

FEBS letters • Vol. 59, Issue 1 • 1975
PMID: 5307DOI: 10.1016/0014-5793(75)80333-4

Documentation

Similar Products